company
as of 2026-07-01Nathan Kline Institute for Psychiatric Research
at a glance
33 trials sponsored · 34 assets in the graph
Synthesized from structured facts only — each point cited above.
Financials
SEC EDGAR XBRL · latest period per metric
No financials loaded for this company (may be non-US-listed — recorded as a gap, not faked).
Pipeline
34 assets
ClozapineHaloperidolOlanzapineQuetiapineRisperidoneAL-108Active Transcranial direct current stimulation (tDCS)Auditory RemediationBetahistineCRT and Social CognitionCRT+ Social Cognition TrainingCapsule with folate, Vitamin B12 & pyridoxineCognitive Remediation (CRT)Cognitive Remediation TherapyComputerized Cognitive Skill TrainingConversion to Antipsychotic MonotherapyD SerineD-serineDronabinolLife style diet groupMK-0777MarijuanaMetforminOrg 24448PioglitazoneSensory Based remediation paradigmSodium ButyrateSodium OxybateTDCSVareniclineVisual Trainingd-cycloserineglycinetranscranial direct current stimulation
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
asset
Clozapine
drugsmall molecule
Haloperidol
drugsmall molecule
Olanzapine
drugsmall molecule
Quetiapine
drugsmall molecule
Risperidone
drugsmall molecule
AL-108
drugsmall molecule
Auditory Remediation
drugBEHAVIORAL